Skip to main content
Clinical Trials/NCT05929573
NCT05929573
Completed
Not Applicable

Efficacy of Renal Doppler Resistive Index and Neutrophil Gelatinase-Associated Lipocalin Measurement in Detecting Acute Kidney Injury in Major Abdominal Surgery

Antalya Training and Research Hospital1 site in 1 country43 target enrollmentJuly 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Antalya Training and Research Hospital
Enrollment
43
Locations
1
Primary Endpoint
Renal Doppler Resistive Index
Status
Completed
Last Updated
last year

Overview

Brief Summary

Acute kidney injury (AKI), which can occur after major surgeries, leads to increased morbidity and mortality if not detected and managed promptly. In clinical practice, serum creatinine and urine output values of patients are monitored to detect AKI, but these parameters can cause delays in diagnosis. Additionally, studies have been conducted on biomarkers such as Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cystatin C in recent years, but definitive results have not been achieved.

Renal Doppler Resistive Index (RDRI) is a non-invasive index believed to reflect renal vascular perfusion. RDRI measurement is a repeatable, inexpensive, and easy-to-apply technique. RDRI has been found to be associated with AKI in conditions such as renal dysfunction, hypertension, and post-traumatic hemorrhagic shock. Furthermore, due to the impact on renal perfusion in patients undergoing major surgery, RDRI, which reflects renal vascular resistance, can serve as an indicator of kidney perfusion.

The aim of this study is to test the hypothesis, 'Does measuring postoperative RDRI in major abdominal surgery cases yield higher sensitivity and specificity values in detecting acute kidney injury compared to NGAL?'

Registry
clinicaltrials.gov
Start Date
July 1, 2023
End Date
July 20, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Antalya Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Erhan Ozyurt

Associate Professor, M.D.

Antalya Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • ASA I-III,
  • Patients undergoing elective major abdominal surgery

Exclusion Criteria

  • Chronic kidney failure,
  • Using nephrotoxic drugs,
  • Patients with a history of kidney transplantation or nephrectomy

Outcomes

Primary Outcomes

Renal Doppler Resistive Index

Time Frame: Postoperative 4th hour

Renal Doppler Resistive Index will be measured at the 4th hour after major abdominal surgery.

Plasma NGAL Level

Time Frame: Postoperative 4th hour

From patients undergoing major abdominal surgery, a blood sample will be taken at Postop 4th Hour for serum NGAL analysis

Study Sites (1)

Loading locations...

Similar Trials